IntegraGen announced unaudited revenue results for the full year 2022. The 2022 unaudited revenue amount to EUR 12,592,000 in 2022, representing an increase of 16% compared to 2021. This growth in all activities reflects the firmness of the company's positioning, both in terms of its main sequencing activities for R&D customers and its expertise in operating platforms on behalf of third parties.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6 EUR | +1.69% | 0.00% | -32.89% |
2023 | IntegraGen SA Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2023 | IntegraGen SA Announces Revenue Results for the First Half of 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-32.89% | 4.18M | |
-20.55% | 10.82B | |
+47.97% | 3.25B | |
-32.75% | 2.11B | |
-14.15% | 2.08B | |
-26.06% | 1.48B | |
+19.85% | 1.02B | |
-2.62% | 733M | |
-31.67% | 391M | |
-43.88% | 383M |
- Stock Market
- Equities
- ALINT Stock
- News IntegraGen
- IntegraGen Announces Unaudited Revenue Results for the Full Year 2022